GGrantIndex
Sort

130,381 grants matching hiv

Caribbean Exploratory Research Center Phase II: Building On Our Progress

$1,160,898
Gloria E Callwood · University Of The Virgin Islands · P20 · FY2015 · MD

UW Clinical HIV Integrated Research Program

$1,160,810
Ann Cornwall Collier · University Of Washington · U01 · FY2010 · AI

Novel Proteomics Approach to HIV-Associated Neurocognitive Disorder & Drug Abuse

$1,160,687
Stuart A Lipton · Scripps Research Institute, The · DP1 · FY2018 · DA

Colorado AIDS Clinical Trials Unit

$1,160,608
Thomas B. Campbell · University Of Colorado Denver · UM1 · FY2012 · AI

Promoting Viral Suppression through the CHAMPS+ Intervention in the Deep South

$1,160,456
Rebecca Schnall · Columbia University Health Sciences · R01 · FY2023 · MD

NATURAL HISTORY OF HIV INFECTION IN INJECTION DRUG USERS

$1,160,398
Johns Hopkins University · R37 · FY2000 · DA

Production of Pedigreed SPF Rhesus Macaques

$1,160,398
Jeffrey A Roberts · University Of California At Davis · U42 · FY2016 · OD

CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics

$1,160,313
Pamela J Bjorkman · University Of Utah · U54 · FY2022 · AI

Early Antiretroviral Therapy and HIV Remission in Perinatal Infection

$1,160,228
Deborah Persaud · Johns Hopkins University · R01 · FY2016 · HD

CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment

$1,160,092
Quarraisha Abdool Karim · Centre/Aids Programme/Res/South Africa · UM1 · FY2015 · AI

Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine

$1,159,913
Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2011 · AI

PS10-1001, HIV PREVENTION PROJECTS

$1,159,720
Jennifer Brown · Utah State Department Of Health · U62 · FY2011 · PS

EXPANDED and INTERGRATED HIV TESTING for POPULATIONS DISPROPORTIONTELY AFFECTED

$1,159,430
Marlene McNeese-Ward · Houston Department/Health/Human Srvs · U62 · FY2009 · PS

Synthesis of Therapeutic Agents for Treatment of Infectious Diseases

$1,159,409
John Givens · Starks Associates, Inc. · N01 · FY2018 · AI

Dimandelic Acid Ethers As Topical Microbicides For HIV

$1,159,341
Mount Sinai School Of Medicine Of Nyu · P01 · FY2003 · HD

Experimental Therapeutics of Pediatric Hematopoietic Malignancies

$1,159,275
Alan S Wayne · Division Of Clinical Sciences - Nci · ZIC · FY2009 · CA

The Data Science Center for the Study of Surgery and Injury in Africa (D-SINE-Africa)

$1,159,239
Alain Mefire Chichom · University Of Buea · U54 · FY2025 · TW

Interventions to decrease HIV infectiousness in Uganda

$1,159,185
Connie L Celum · University Of Washington · RC4 · FY2012 · AI

PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS

$1,159,132
Laurie Kops · Montana State Dept/Pub Hlth & Human Srvs · U62 · FY2012 · PS

Signaling Pathways Modulating HIV-1 Induced Injury in CNS

$1,158,918
Shohreh Amini · Temple Univ Of The Commonwealth · P01 · FY2009 · NS

Efficacy/Effectiveness of Unhealthy Drug Use Screening/Brief Intervention Models

$1,158,668
Richard Saitz · Boston Medical Center · R01 · FY2009 · DA

Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors

$1,158,393
Kenner Rice · National Institute On Drug Abuse · ZIA · FY2014 · DA

Immunotherapeutic Approaches for AIDS

$1,158,141
George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Implementation of telemedicine and social network driven HIV service uptake for comprehensive HIV service integration in rural syringe service programs

$1,158,132
Oluwaseun Falade-Nwulia · Johns Hopkins University · R01 · FY2024 · DA

Metabolic and Immunologic Effects of Meditation

$1,158,102
Frederick M Hecht · University Of California, San Francisco · P01 · FY2011 · AT